Search This Blog

Friday, August 9, 2019

Biohaven Pharmaceuticals EPS misses by $3.40

Biohaven Pharmaceuticals (NYSE:BHVN): Q2 GAAP EPS of -$4.67 misses by $3.40.
Cash of $465.74M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)